|
시장보고서
상품코드
2050805
차세대 시퀀싱(NGS) 시장 : 제품 유형별, 시퀀싱 방식별, 용도별, 최종사용자별, 지역별Next Generation Sequencing Market, By Product Type, By Sequencing Type, By Application, By End User, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
차세대 시퀀싱(NGS) 시장은 2026년에 217억 6,000만 달러로 추정되며, 2033년까지 575억 4,000만 달러에 이를 전망입니다. 또한 2026-2033년 CAGR 14.9%를 나타낼 것으로 예측됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 217억 6,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 14.90% | 2033년 시장 규모 예측 : | 575억 4,000만 달러 |
차세대 시퀀싱(NGS)은 1세대 싱거 시퀀싱에 비해 DNA 시퀀싱 비용을 대폭 절감하고 속도와 처리 능력을 향상시킨 고처리량 DNA 시퀀싱 기술을 말합니다. NGS를 통해 연구자들은 전체 유전체을 시퀀싱할 수 있을 뿐만 아니라 유전자 활성과 발현 패턴을 대규모로 분석할 수 있습니다. 2005년 발견 이후 NGS 플랫폼은 비약적인 발전을 거듭하여 한 번의 실행으로 수천에서 수백만 개의 DNA 조각을 시퀀싱할 수 있게 되었습니다. 초병렬 시퀀싱은 유전체 연구에서 종합적인 특성 분석과 발견을 가능하게 하여 생물학 및 생의학 연구에 혁명을 일으켰습니다. NGS는 유전학, 종양학, 약물유전체학, 맞춤의료 등 다양한 분야에 적용되고 있습니다.
시장 역학
세계 차세대 염기서열 분석 시장의 성장은 다양한 질병에 대한 유전체학 및 정밀의료의 적용 확대에 의해 주도되고 있습니다. 암 유병률 증가와 약물유전체학에 대한 관심이 높아지면서 임상 진단 및 모니터링 분야에서 NGS 플랫폼에 대한 수요가 증가하고 있습니다. 유전체 연구 활동의 활성화와 더불어 시퀀싱 비용의 지속적인 하락, 휴대가 간편하고 사용하기 쉬운 시퀀싱 장비의 도입도 시장 성장을 견인하고 있습니다. 그러나 NGS에서 생성되는 방대한 데이터로 인한 데이터 관리 및 분석의 어려움, 그리고 바이오인포매틱스에 대한 지식 부족은 여전히 과제로 남아있습니다. 한편, 단일 세포 분석에의 적용과 NGS 데이터 관리를 위한 클라우드 기반 솔루션 개발은 유망한 성장 기회를 제공합니다.
본 조사의 주요 특징
- 이 보고서는 각 부문의 잠재적 수익기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 성장 촉진요인, 시장 성장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택한 경쟁 전략에 대한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음과 같은 매개 변수를 기반으로 세계 차세대 시퀀싱(NGS) 시장의 주요 기업 프로파일을 작성했습니다. 구체적으로 기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적 및 전략 등입니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 모델 업그레이드, 시장 확대 및 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것입니다.
- 이 세계 차세대 시퀀싱(NGS) 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 차세대 시퀀싱(NGS) 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 차세대 시퀀싱(NGS) 시장 : 제품 유형별, 2026년-2033년
제5장 세계의 차세대 시퀀싱(NGS) 시장 : 시퀀싱 방식별, 2026년-2033년
제6장 세계의 차세대 시퀀싱(NGS) 시장 : 용도별, 2026년-2033년
제7장 세계의 차세대 시퀀싱(NGS) 시장 : 최종사용자별, 2026년-2033년
제8장 세계의 차세대 시퀀싱(NGS) 시장 : 지역별, 2026년-2033년
제9장 경쟁 구도
제10장 애널리스트의 견해
제11장 참고 문헌 및 조사 방법
LSHNext Generation Sequencing Market is estimated to be valued at USD 21.76 Bn in 2026 and is expected to reach USD 57.54 Bn by 2033, growing at a compound annual growth rate (CAGR) of 14.9% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 21.76 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 14.90% | 2033 Value Projection: | USD 57.54 Bn |
Next Generation Sequencing (NGS) refers to the high-throughput DNA sequencing technologies that have substantially decreased the cost and increased the speed and throughput of DNA sequencing as compared to the first-generation Sanger sequencing. NGS allows researchers to sequence entire genomes, as well as to analyze the patterns of gene activity or expression on a large scale. Since its discovery in 2005, there have been tremendous improvements in NGS platforms which has enabled the sequencing of thousands to millions of DNA fragments in a single run. This massively parallel sequencing has revolutionized biological and biomedical research by allowing comprehensive characterization and discovery in genomic research. NGS finds applications across various fields including genetics, oncology, pharmacogenomics and personalized medicine.
Market Dynamics
The global next generation sequencing market growth is driven by growing applications of genomics and precision medicine across various diseases. Rising prevalence of cancer and growing focus on pharmacogenomics is fueling the demand for NGS platforms in clinical diagnosis and monitoring. Growing genomics research activities, coupled with continuous decline in sequencing costs and introduction of portable and user-friendly sequencing instruments is also boosting the market growth. However, data management and analysis issues due to the massive amount of data generated from NGS, and limited bioinformatics knowledge remains a challenge. Meanwhile, developments in single-cell applications and cloud-based solutions for NGS data management presents lucrative growth opportunities.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global next generation sequencing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study includes Thermo Fisher Scientific Inc., Agilent Technologies Inc, bioMerieux SA, F. Hoffmann-La Roche Ltd, QIAGEN, Illumina Inc., Oxford Nanopore Technologies plc., BGI, PerkinElmer Genomics, Bio-Rad Laboratories Inc., Pacific Biosciences, 10x Genomics, Promega Corporation, Macrogen Inc., Eurofins Scientific, DNASTAR Inc., and CD Genomics.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global next generation sequencing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global next generation sequencing market.
Market Segmentation
- Product Type Insights (Revenue, USD Bn, 2026 - 2033)
- Instruments
- Reagents & Consumables
- Sequencing Type Insights (Revenue, USD Bn, 2026 - 2033)
- Whole Genome Sequencing
- Whole Exome Sequencing
- RNA Sequencing
- Targeted Re-sequencing
- Others
- Application Insights (Revenue, USD Bn, 2026 - 2033)
- Drug Discovery
- Personalized Medicine
- Genetic Screening
- Diagnostics
- Others
- End User Insights (Revenue, USD Bn, 2026 - 2033)
- Hospitals & Clinics
- Academic & Research Institutes
- Biopharmaceutical Companies
- Clinical Laboratories
- Others
- Regional Insights (Revenue, USD Bn, 2026 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Pradeep Tripathi
- Key Players Insights
- Thermo Fisher Scientific Inc.
- Agilent Technologies Inc
- bioMerieux SA
- F. Hoffmann-La Roche Ltd
- QIAGEN
- Illumina Inc.
- Oxford Nanopore Technologies plc.
- BGI
- PerkinElmer Genomics
- Bio-Rad Laboratories Inc.
- Pacific Biosciences
- 10x Genomics
- Promega Corporation
- Macrogen Inc.
- Eurofins Scientific
- DNASTAR Inc.
- CD Genomics
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Sequencing Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Recent Developments
- Acquisitions and Partnerships Scenario
- Technology Overview
- Regulatory Scenario
- Pricing Analysis
- PEST Analysis
4. Global Next Generation Sequencing Market, By Product Type, 2026 - 2033, (US$ Billion)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Instruments
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
- Reagents & Consumables
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
5. Global Next Generation Sequencing Market, By Sequencing Type, 2026 - 2033, (US$ Billion)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Whole Genome Sequencing
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
- Whole Exome Sequencing
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
- RNA Sequencing
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
- Targeted Re-sequencing
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
6. Global Next Generation Sequencing Market, By Application, 2026 - 2033, (US$ Billion)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Drug Discovery
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
- Personalized Medicine
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
- Genetic Screening
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
- Diagnostics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
7. Global Next Generation Sequencing Market, By End User, 2026 - 2033, (US$ Billion)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Hospitals & Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
- Academic & Research Institutes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
- Biopharmaceutical Companies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
- Clinical Laboratories
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
8. Global Next Generation Sequencing Market, By Region, 2026 - 2033, (US$ Billion)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2026-2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Sequencing Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Sequencing Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Sequencing Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
- UK
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Sequencing Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Sequencing Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Sequencing Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2026 - 2033, (US$ Billion)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Agilent Technologies, Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- bioMerieux SA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- F. Hoffmann-La Roche Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- QIAGEN
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Illumina, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Oxford Nanopore Technologies plc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- BGI
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- PerkinElmer Genomics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bio-Rad Laboratories Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Pacific Biosciences
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- 10x Genomics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Promega Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Macrogen Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Eurofins Scientific
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- DNASTAR Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- CD Genomics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
10. Analyst View
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
